Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa
1d agoen
From the article
Conditions : Hidradenitis Suppurativa (HS) Interventions : Drug: Roflumilast 0.3% topical foam Sponsors : Harrison Dermatology Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Surgery remains a viable option for faster relief in hidradenitis suppurativa, expert says
Dermatology expert Dr. Amit Garg argues that surgery should no longer be viewed as a last resort for hidradenitis suppurativa (HS), despite

Spatial Analysis Reveals Socioenvironmental Drivers of Hidradenitis Suppurativa in Boston Area
This cross-sectional study uses spatial epidemiological methods to analyze how environmental and social factors influence the distribution o
FDA approves bemotrizinol, first new sunscreen ingredient in over 25 years
The FDA has approved bemotrizinol, the first new sunscreen ingredient for the U.S. market in over 25 years. The ingredient, long used in Eur
FDA approves bemotrizinol, first new sunscreen ingredient in over 25 years
The FDA has approved bemotrizinol, the first new sunscreen ingredient for the U.S. market in over 25 years. The ingredient, already used in
denverpost.com·29d ago
Guía definitiva para entender la protección solar: «Es mucho más que echarse crema»
todoalicante.es·1d ago

Guía definitiva para entender la protección solar: «Es mucho más que echarse crema»
todoalicante.es·1d ago
FDA approves bemotrizinol, first new sunscreen ingredient in nearly 30 years
The FDA has approved bemotrizinol, a new chemical UV filter for sunscreens, marking the first such approval in nearly 30 years. The ingredie

Comments
Sign in to join the conversation.
No comments yet. Be the first.